WikiCRO (CEO Heo Chan-young) announced that it will participate in the 3th International Medical Equipment and Hospital Equipment Exhibition ‘KIMES 23’, which will be held at COEX, Seoul from March 26rd (Thursday) to 38th (Sunday).
WikiCRO is a company that provides one-stop CRO services and comprehensive solutions. It has a wide range of service areas, including clinical trials for approval ranging from exploratory (Phase 1 clinical trials) to confirmation (Phase 3 clinical trials) and post-approval clinical trials such as researcher-led clinical trials, Phase 4 clinical trials, PMS, and observational studies. In addition, during the process, we are responsible for everything from CRO to non-clinical and clinical trial subject recruitment and management, supporting multifaceted tasks to ensure that actual clinical trials proceed smoothly.
At the same time, it is evaluated as having specialized capabilities in the in vitro diagnostic, medical device, and digital therapeutic device markets, which have recently emerged as a blue ocean. As part of this, we are expanding our network by joining and continuing collaboration with related organizations and institutions such as the Korean Society for Digital Therapy, the Korean Society for Medical Informatics, Digital Health Korea Expo, Korea Digital Health Industry Association, and the Korea Smart Medical Device Industry Promotion Foundation.
WikiCRO plans to promote its service capabilities through this exhibition and seek exchange and collaboration with a wider range of companies.
The company explains that their services provide the highest level of service through their own infrastructure, including rich experience, support systems, and specialized personnel in each service field. In addition to work design, the company also emphasized the advantages of systematic work processing, efficient communication, and maximizing time and cost efficiency in non-clinical, clinical, and approval approvals.
In addition, the official explained that the company plans to expand its business area to include the platform business through collaboration with IT companies and thereby strengthen its leadership in the global healthcare market.
An official said, “Through our experience in carrying out projects in various treatment areas and clinical trial stages, we have the ability to perform high-level clinical trials that meet global standards,” and “As the so-called leading CRO in Korea, we are leading the development of the domestic CRO industry. “We will do our best to advance the domestic healthcare industry into the global market,” he said.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.